Additionally, in CRC and gastric cancer, TAMs have been shown to upregulate IDO1, which converts tryptophan into kynurenine, a key immunosuppressive metabolite that dampens T-cell activation and promotes immune evasion. This evidence concerns the gene IDO1 and gastric cancer.